ATE443765T1
(de)
|
2003-03-21 |
2009-10-15 |
Santaris Pharma As |
Analoga kurzer interferierender rna (sirna)
|
WO2005068616A2
(en)
|
2004-01-16 |
2005-07-28 |
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. |
Immunokinases
|
US20070213293A1
(en)
*
|
2005-04-08 |
2007-09-13 |
Nastech Pharmaceutical Company Inc. |
Rnai therapeutic for respiratory virus infection
|
EP1800695A1
(en)
|
2005-12-21 |
2007-06-27 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Immuno-RNA-constructs
|
JP5244087B2
(ja)
*
|
2006-03-23 |
2013-07-24 |
サンタリス ファーマ アー/エス |
低分子内部セグメント化干渉rna
|
EP2064223B1
(en)
*
|
2006-09-22 |
2013-04-24 |
Dharmacon, Inc. |
Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
|
WO2008049078A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Nastech Pharmaceutical Company Inc. |
Nicked or gapped nucleic acid molecules and uses thereof
|
DE102007008596B4
(de)
|
2007-02-15 |
2010-09-02 |
Friedrich-Schiller-Universität Jena |
Biologisch wirksame Moleküle auf Grundlage von PNA und siRNA, Verfahren zu deren zellspezifischen Aktivierung sowie Applikationskit zur Verabreichung
|
WO2008109509A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting snca gene expression and uses thereof
|
WO2008109494A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting stat3 gene expression and uses thereof
|
WO2008109555A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting nrg1 gene expression and uses thereof
|
WO2008109461A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting cd3 gene expression and uses thereof
|
WO2008109526A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting egr gene expression and uses thereof
|
WO2008109500A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting prkca gene expression and uses thereof
|
WO2008109532A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting fas gene expression and uses thereof
|
WO2008109373A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
|
WO2008109490A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting chek1 gene expression and uses thereof
|
WO2008109498A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting hdac gene expression and uses thereof
|
CA2679342A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof
|
WO2008109544A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting muc1 gene expression and uses thereof
|
EP2126085A2
(en)
*
|
2007-03-02 |
2009-12-02 |
MDRNA, Inc. |
Nucleic acid compounds for inhibiting myc gene expression and uses thereof
|
WO2008109379A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting il17a gene expression and uses thereof
|
US20080299659A1
(en)
*
|
2007-03-02 |
2008-12-04 |
Nastech Pharmaceutical Company Inc. |
Nucleic acid compounds for inhibiting apob gene expression and uses thereof
|
WO2008109495A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting cd40 gene expression and uses thereof
|
WO2008109556A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting telomerase gene expression and uses thereof
|
WO2008109492A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting igf1r gene expression and uses thereof
|
WO2008109518A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting wnt gene expression and uses thereof
|
US20100112687A1
(en)
*
|
2007-03-02 |
2010-05-06 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
|
WO2008109475A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting sirt2 gene expression and uses thereof
|
WO2008109370A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting srd5a1 gene expression and uses thereof
|
WO2008109548A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting tgfb gene expression and uses thereof
|
WO2008109378A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting pdgfr gene expression and uses thereof
|
WO2008109359A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting pdgfr family gene expression and uses thereof
|
CA2679388A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting ras gene expression and uses thereof
|
WO2008109547A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting tymp gene expression and uses thereof
|
WO2008109531A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Ndrna, Inc. |
Nucleic acid compounds for inhibiting hsd11b1 expression and uses thereof
|
WO2008109553A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting ptpn11 gene expression and uses thereof
|
CA2679347A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna Inc. |
Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof
|
WO2008109380A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
|
WO2008109520A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting cxc gene expression and uses thereof
|
WO2008109443A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting cdk2 gene expression and uses thereof
|
WO2008109382A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting pkn3 gene expression and uses thereof
|
WO2008109371A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting p38 mapk family gene expression and uses thereof
|
WO2008109487A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting mme gene expression and uses thereof
|
WO2008109506A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting jun gene expression and uses thereof
|
WO2008109365A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting raf1 gene expression and uses thereof
|
WO2008109372A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting pdgf gene expression and uses thereof
|
WO2008109364A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof
|
WO2008109368A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof
|
WO2008109473A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting abcb1 gene expression and uses thereof
|
WO2008109503A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting ms4a1 gene expression and uses thereof
|
WO2008109354A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting il18 gene expression and uses thereof
|
WO2008109511A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting fcer2 gene expression and uses thereof
|
WO2008109546A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof
|
WO2008109497A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting folh1 gene expression and uses thereof
|
WO2008109356A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting tnfsf13b gene expression and uses thereof
|
WO2008109350A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting il6 gene expression and uses thereof
|
WO2008109376A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting bcr-abl gene expression and uses thereof
|
WO2008109468A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting mmp gene expression and uses thereof
|
WO2008109493A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
|
WO2008109353A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting map2k gene expression and uses thereof
|
WO2008109454A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting fos gene expression and uses thereof
|
WO2008109374A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting mapk gene expression and uses thereof
|
WO2008109488A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting angpt2 gene expression and uses thereof
|
US20100047909A1
(en)
*
|
2007-03-02 |
2010-02-25 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting vegf family gene expression and uses thereof
|
WO2008109366A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting ccnd1 gene expression and uses thereof
|
WO2008109375A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting pik3c gene expression and uses thereof
|
WO2008109352A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting akt gene expression and uses thereof
|
US20080286866A1
(en)
*
|
2007-03-02 |
2008-11-20 |
Nastech Pharmaceutical Company Inc. |
Nucleic acid compounds for inhibiting vegf gene expression and uses thereof
|
WO2008109355A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting srd5a2 gene expression and uses thereof
|
WO2008109505A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting cd22 gene expression and uses thereof
|
WO2008109369A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting tnf gene expression and uses thereof
|
WO2008109358A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting mapk1 gene expression and uses thereof
|
WO2008109551A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting tacstd1 gene expression and uses thereof
|
WO2008109558A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting tlr gene expression and uses thereof
|
WO2008109534A1
(en)
*
|
2007-03-02 |
2008-09-12 |
Mdrna, Inc. |
Nucleic acid compounds for inhibiting ezh2 gene expression and uses thereof
|
WO2009078470A1
(ja)
*
|
2007-12-18 |
2009-06-25 |
National Institute Of Advanced Industrial Science And Technology |
多糖/2本鎖rna複合体
|
DE102009043743B4
(de)
*
|
2009-03-13 |
2016-10-13 |
Friedrich-Schiller-Universität Jena |
Zellspezifisch wirksame Moleküle auf Grundlage von siRNA sowie Applikationskits zu deren Herstellung und Verwendung
|
US11414664B2
(en)
|
2008-12-18 |
2022-08-16 |
Dicerna Pharmaceuticals, Inc. |
Extended dicer substrate agents and methods for the specific inhibition of gene expression
|
US20100184841A1
(en)
*
|
2008-12-18 |
2010-07-22 |
Dicerna Pharmaceuticals, Inc. |
Extended dicer substrate agents and methods for the specific inhibition of gene expression
|
WO2010093788A2
(en)
|
2009-02-11 |
2010-08-19 |
Dicerna Pharmaceuticals, Inc. |
Multiplex dicer substrate rna interference molecules having joining sequences
|
WO2011028550A1
(en)
|
2009-08-24 |
2011-03-10 |
Merck Sharp & Dohme Corp. |
Segmented micro rna mimetics
|
AU2010306940A1
(en)
|
2009-10-12 |
2012-06-07 |
Smith, Larry |
Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
|
CA2785727C
(en)
*
|
2009-12-31 |
2020-01-07 |
Curna, Inc. |
Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
|
KR101678876B1
(ko)
*
|
2010-01-15 |
2016-11-23 |
한국과학기술원 |
복합 유전자를 표적하는 siRNA 다중 접합체 및 이의 제조방법
|
DE102010009445A1
(de)
*
|
2010-02-25 |
2011-08-25 |
Universitätsklinikum Jena, 07743 |
Expressionsvektor zur Enzym-Expression in Zellen und Verfahren zu dessen Verwendung
|
UY33326A
(es)
|
2010-04-14 |
2011-12-01 |
Sanofi Aventis |
Conjugados de insulina-sirna
|
WO2012068187A1
(en)
*
|
2010-11-19 |
2012-05-24 |
Merck Sharp & Dohme Corp. |
Poly(amide) polymers for the delivery of oligonucleotides
|
PT2983706T
(pt)
*
|
2013-04-10 |
2021-06-18 |
Aarhus Univ University Of Aarhus |
Utilização de domínios imunossupressores como medicamentos
|
JP2019503394A
(ja)
|
2016-01-31 |
2019-02-07 |
ユニバーシティ・オブ・マサチューセッツUniversity Of Massachusetts |
分岐オリゴヌクレオチド
|
CA3109133A1
(en)
|
2018-08-10 |
2020-02-13 |
University Of Massachusetts |
Modified oligonucleotides targeting snps
|
EP3911747A4
(en)
*
|
2019-01-18 |
2023-05-24 |
University Of Massachusetts |
DYNAMIC PHARMACOKINETICS-MODIFYING ANCHORS
|
EP4359539A1
(en)
|
2021-06-23 |
2024-05-01 |
University Of Massachusetts |
Optimized anti-flt1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
|